Zhijie Wang
Clinical trials sponsored by Zhijie Wang, explained in plain language.
-
New drug combo targets 'Undruggable' lung cancer
Disease control Not yet recruitingThis study is testing a new combination treatment for people with a specific, hard-to-treat form of advanced lung cancer (SMARCA4-deficient). All participants will receive an oral pill called anlotinib alongside standard platinum-based chemotherapy. The main goals are to see if t…
Phase: PHASE2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New hope for deadly lung cancer? trial tests promising drug combo
Disease control Not yet recruitingThis study is testing a new combination treatment for people with an aggressive, hard-to-treat type of advanced lung cancer. It combines a new two-in-one immunotherapy drug (which targets two different immune system pathways) with standard chemotherapy. The goal is to see if this…
Phase: PHASE2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC